Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

MDC Researchers Gain New Insights into Epilepsy

27.03.2014

Just as each musician in an orchestra contributes to the overall sound of a musical piece, different types of nerve cells in the brain make up the symphony of our consciousness.

They regulate and coordinate the activity of groups of neurons that represent parts of information, which they then may transmit to other brain regions. If this precise system is thrown off balance, diseases can develop.


In order to identify the nerve cells in the neuronal network which express the altered glycine receptor researchers inserted an extra gene segment that illuminates the nerve cells (purple). (Photo: Jochen Meier/Copyright: MDC)

Professor Jochen Meier of the Max Delbrück Center (MDC) investigates such processes. Together with his colleagues, he has gained new insights into epilepsy, showing why the disease may present different symptoms (Journal of Clinical Investigation, doi:10.1172/JC171472)*.

The research focus is on the glycine receptor, known from previous studies in the field of spinal cord research as an inhibitory neurotransmitter receptor. Several years ago the research group of neurobiologists showed that this receptor is molecularly altered in patients with intractable temporal lobe epilepsy, one of the most common forms of epilepsy.

Expression of the altered receptor is increased in the hippocampus, a region of the brain that triggers seizures in most patients at later stages of the disease.

Professor Meier, who leads a Helmholtz junior research group at the explained that epilepsy is not exclusively inherited, that is, its cause need not be genetic. In fact, recent research data indicate that various environmental factors, including chronic stress, can cause epileptic seizures.

Resulting molecular and cellular mechanisms may change neuroplasticity to the extent that the affected tissue is no longer able to restore the normal state, which can then lead to chronic epilepsy. This may be one reason why the disease course differs from patient to patient.

The molecular alteration of the glycine receptor in the tissue of epilepsy patients is caused by a process known in research as “RNA editing”. Thereby, in the process of transcription of genetic information from DNA to RNA, individual letters are replaced with others. Enzymes are responsible for the editing of the text.

As a result, the original genetic text encoded in the DNA language no longer corresponds exactly to the RNA, which contains the code for the text building blocks of the proteins. The protein, in this case the glycine receptor, is altered so that it expresses a gain-of-function, and thus functions far more effectively than its non-edited counterpart.

Together with colleagues from Israel and different German universities, Dr. Aline Winkelmann and Professor Meier developed a new animal model of epilepsy to determine the role of this particular glycine receptor variant. This allowed them to express this receptor specifically in selected nerve cell types of the hippocampus and to investigate how it affects cognitive function and mood-related behavior.

They found that the RNA-edited gain-of-function receptor targets the presynaptic terminals, which transfer electrical impulses by releasing a neurotransmitter to other nerve cells. Thus, the function of selected types of nerve cells is strengthened, whereby the whole system of neuronal communication is thrown off balance.

Depending on whether excitatory or inhibitory nerve cells expressed the receptor, the mice were impaired in their cognitive abilities including memory deficits, or they showed increased anxiety.

“Our new animal model suggests that the same molecule can contribute to a wide range of symptoms in epilepsy patients – for example, cognitive dysfunction or anxiety – depending on which type of nerve cell expresses it,” Professor Meier said.

He and his colleagues have thus discovered a disease mechanism which they hope will open up new approaches to the development of targeted treatments for epilepsy patients. He stressed, however, “We must also identify the conductor of this cellular orchestra of dissonant molecular components that is responsible for receptor expression in varied nerve cells in the hippocampus of epilepsy patients.”

*Changes in neural network homeostasis trigger neuropsychiatric symptoms

Aline Winkelmann,1,2 Nicola Maggio,3 Joanna Eller,4 Gürsel Caliskan,5 Marcus Semtner,2 Ute Häussler,6 René Jüttner,7 Tamar Dugladze,4 Birthe Smolinsky,8 Sarah Kowalczyk,8 Ewa Chronowska,9 Günter Schwarz,8 Fritz G. Rathjen,7 Gideon Rechavi,10 Carola A. Haas,6,11 Akos Kulik,9,12 Tengis Gloveli,4,13 Uwe Heinemann,5 and Jochen C. Meier2

1FU-Berlin, Fachbereich Biologie, Chemie, Pharmazie, Berlin, Germany. 2RNA editing and Hyperexcitability Disorders Helmholtz Group, Max Delbrück Center for Molecular Medicine, Berlin, Germany. 3Talpiot Medical Leadership Program, Department of Neurology and the J. Sagol Neuroscience Center, The Chaim Sheba Medical Center, Tel HaShomer, Israel. 4Cellular and Network Physiology Group, Institute of Neurophysiology, Charité Universitätsmedizin Berlin, Berlin, Germany. 5CC2 Zentrum für Physiologie, Freie Universität Berlin, Berlin, Germany. 6Experimental Epilepsy Research, Department of Neurosurgery, Neurocenter, University of Freiburg, Freiburg, Germany. 7Developmental Neurobiology, Max Delbrück Center for Molecular Medicine, Berlin, Germany. 8Institute of Biochemistry, University of Cologne and Center for Molecular Medicine, Cologne, Germany. 9Department of Physiology II, University of Freiburg, Freiburg, Germany. 10Sheba Cancer Research Center, The Chaim Sheba Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. 11BrainLinks-BrainTools, Cluster of Excellence and 12BIOSS Centre for Biological Signalling Studies, University of Freiburg, Freiburg, Germany. 13Bernstein Center for Computational Neuroscience Berlin, Berlin, Germany.

Contact:
Barbara Bachtler
Press Department
Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch
in the Helmholtz Association
Robert-Rössle-Straße 10
13125 Berlin
Germany
Phone: +49 (0) 30 94 06 - 38 96
Fax: +49 (0) 30 94 06 - 38 33
e-mail: presse@mdc-berlin.de
http://www.mdc-berlin.de/

Weitere Informationen:

http://www.mdc-berlin.de/1158081/en/research/research_teams/rna_editing_and_hype...

Barbara Bachtler | Max-Delbrück-Centrum

Further reports about: Epilepsy Helmholtz MDC Max-Delbrück-Centrum Molecular RNA cognitive glycine receptor

More articles from Life Sciences:

nachricht The birth of a new protein
20.10.2017 | University of Arizona

nachricht Building New Moss Factories
20.10.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Terahertz spectroscopy goes nano

20.10.2017 | Information Technology

Strange but true: Turning a material upside down can sometimes make it softer

20.10.2017 | Materials Sciences

NRL clarifies valley polarization for electronic and optoelectronic technologies

20.10.2017 | Interdisciplinary Research

VideoLinks
B2B-VideoLinks
More VideoLinks >>>